chr1-16251131-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018994.3(FBXO42):c.1693G>A(p.Ala565Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000123 in 1,461,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018994.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO42 | NM_018994.3 | c.1693G>A | p.Ala565Thr | missense_variant | 10/10 | ENST00000375592.8 | NP_061867.1 | |
FBXO42 | XM_047422747.1 | c.1693G>A | p.Ala565Thr | missense_variant | 12/12 | XP_047278703.1 | ||
FBXO42 | XM_047422750.1 | c.1693G>A | p.Ala565Thr | missense_variant | 12/12 | XP_047278706.1 | ||
FBXO42 | XM_047422751.1 | c.1693G>A | p.Ala565Thr | missense_variant | 12/12 | XP_047278707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO42 | ENST00000375592.8 | c.1693G>A | p.Ala565Thr | missense_variant | 10/10 | 1 | NM_018994.3 | ENSP00000364742.3 | ||
FBXO42 | ENST00000444116.1 | c.847G>A | p.Ala283Thr | missense_variant | 4/4 | 5 | ENSP00000412416.1 | |||
FBXO42 | ENST00000456164.5 | c.847G>A | p.Ala283Thr | missense_variant | 3/3 | 2 | ENSP00000415663.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461834Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 727212
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2024 | The c.1693G>A (p.A565T) alteration is located in exon 10 (coding exon 9) of the FBXO42 gene. This alteration results from a G to A substitution at nucleotide position 1693, causing the alanine (A) at amino acid position 565 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at